Resistance to mTOR Kinase Inhibitors in Lymphoma Cells Lacking 4EBP1

Open Access

Peer-reviewed

Research Article

Sharmila Mallya,

Affiliation Department of Molecular Biology & Biochemistry, and Institute for Immunology, University of California Irvine, Irvine, California United States of America
⨯
Briana A. Fitch,

Affiliation Department of Molecular Biology & Biochemistry, and Institute for Immunology, University of California Irvine, Irvine, California United States of America
⨯
J. Scott Lee,

Affiliation Department of Molecular Biology & Biochemistry, and Institute for Immunology, University of California Irvine, Irvine, California United States of America
⨯
Lomon So,

Affiliation Department of Molecular Biology & Biochemistry, and Institute for Immunology, University of California Irvine, Irvine, California United States of America
⨯
Matthew R. Janes,

Affiliation Department of Molecular Biology & Biochemistry, and Institute for Immunology, University of California Irvine, Irvine, California United States of America
⨯
David A. Fruman

* E-mail: dfruman@uci.edu

Affiliation Department of Molecular Biology & Biochemistry, and Institute for Immunology, University of California Irvine, Irvine, California United States of America
⨯

Reader Comments (0)

Luciferase
Is the Subject Area "Luciferase" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Protein synthesis
Is the Subject Area "Protein synthesis" applicable to this article?

Thanks for your feedback.
Lymphoma
Is the Subject Area "Lymphoma" applicable to this article?

Thanks for your feedback.
B cells
Is the Subject Area "B cells" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Messenger RNA
Is the Subject Area "Messenger RNA" applicable to this article?

Thanks for your feedback.
Cell death
Is the Subject Area "Cell death" applicable to this article?

Thanks for your feedback.